ANTIVIRAL PRODRUGS AND NANOFORMULATIONS THEREOF - Patent 4234560

(19)

(11)

EP 4 234 560 A3

(12)	EUROPEAN PATENT APPLICATION

(88)	Date of publication A3:
	13.09.2023 Bulletin 2023/37

(43)	Date of publication A2:
	30.08.2023 Bulletin 2023/35

(21)	Application number: 23160303.6

(22)	Date of filing: 22.10.2019

(51)

International Patent Classification (IPC):

C07D 498/22^(2006.01)
C07D 498/18^(2006.01)
A61K 47/54^(2017.01)

A61P 31/18^(2006.01)
A61K 31/5365^(2006.01)
A61K 9/14^(2006.01)

(52)	Cooperative Patent Classification (CPC):
	C07D 498/14; A61K 31/4985; A61P 31/18; A61K 31/513; A61K 31/47; A61K 31/553; A61K 9/0019; A61K 9/146; A61K 47/542; C07D 498/22

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

22.10.2018 US 201862748798 P

(62)	Application number of the earlier application in accordance with Art. 76 EPC:
	19877349.1 / 3870174

(71)	Applicant: Board of Regents of the University of Nebraska
	Lincoln, NE 68583 (US)

(72)	Inventors:
	GENDELMAN, Howard E. Omaha, 68154 (US) EDAGWA, Benson Omaha, 68131 (US)

(74)	Representative: HGF
	HGF Limited 1 City Walk Leeds LS11 9DX Leeds LS11 9DX (GB)

(54)	ANTIVIRAL PRODRUGS AND NANOFORMULATIONS THEREOF

(57) The present invention provides prodrugs and methods of use thereof.